Yaniris Garcia Cruz
Endocrinology, Diabetes & Metabolism · San Juan, PRNPI 1639527336
Payments from drug & device makers
Across 199 payments — averaging $31.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1K
- Medtronic$809
- Amgen$649
- AstraZeneca$645
- Sanofi-aventis U.S. LLC$511
- Novo Nordisk$380
- plus $2K from 15 others
What the payments were for
- Travel & lodging$5098%
- Food & beverage$5,68391%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 30 | $1,058 |
| Medtronic | 12 | $809 |
| Amgen(2 entities) | 7 | $649 |
| AstraZeneca | 26 | $645 |
| Sanofi-aventis U.S. LLC | 23 | $511 |
| Novo Nordisk | 18 | $380 |
| Eli Lilly Export S.A. Puerto Rico Branch | 17 | $346 |
| Bayer | 6 | $311 |
| Lilly USA, LLC | 4 | $298 |
| Merck | 10 | $197 |
| Abbott | 10 | $170 |
| PBG Puerto Rico LLC | 9 | $167 |
| Johnson & Johnson | 8 | $160 |
| Dexcom, Inc. | 7 | $133 |
| Corcept Therapeutics | 1 | $125 |
| Novartis | 4 | $97 |
| Bayer Puerto Rico Inc. | 2 | $49 |
| AbbVie | 1 | $33 |
| Radius Health, Inc. | 2 | $33 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $29 |
| Insulet Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,224 in reported general payments places this provider in the 55th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 168 | $180,550 |
| TrulicityDulaglutide | 146 | $148,046 |
| OzempicSemaglutide | 73 | $79,186 |
| Xigduo XrDapaglifloz Propaned/Metformin | 117 | $74,894 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 104 | $65,931 |
| FarxigaDapagliflozin Propanediol | 93 | $60,477 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 82 | $52,059 |
| JardianceEmpagliflozin | 52 | $39,183 |
| TradjentaLinagliptin | 45 | $25,824 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 161 | $16,240 |
| Humalog Kwikpen U-100Insulin Lispro | 61 | $10,900 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 14 | $10,275 |
| SynthroidLevothyroxine Sodium | 176 | $9,306 |
| Jentadueto XrLinagliptin/Metformin Hcl | 12 | $6,364 |
| LantusInsulin Glargine,hum.Rec.Anlog | 74 | $5,895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $298 | $328,596314 claims |
| Boehringer IngelheimSynjardy Xr, Trijardy Xr, Jardiance, Tradjenta, Jentadueto Xr | $1,058 | $189,360295 claims |
| Novo NordiskOzempic | $380 | $79,18673 claims |
| AstraZenecaFarxiga | $645 | $60,47793 claims |
| MerckJanumet Xr | $197 | $10,27514 claims |
| AbbVieSynthroid | $33 | $9,306176 claims |
| Sanofi-aventis U.S. LLCLantus | $511 | $5,89574 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in San Juan
- Alex Gonzalez BossoloSan Juan$5.5M
- Martha GomezSan Juan$3.8M
- Michelle Mangual GarciaSan Juan$743K
- Loida Gonzalez RodriguezSan Juan$246K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Oscar Ruiz BermudezSan Juan$94K
- Meliza Martinez RodriguezSan Juan$80K
- Jorge de Jesus MirandaSan Juan$30K
- Zahira Lugo LopezSan Juan$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.